NCT04987346

Normative Database for Gait Analysis on the GRAIL UZ Gent

Name: Clinical Trial NCT04987346
Creator: University Hospital, Ghent
Keywords: Gait, Walking on an instrumented treadmill, other, clinical trial, Belgium

Normative Database for Gait Analyses and Balance on the GRAIL at the University Hospital of Ghent.

University Hospital, Ghent·ClinicalTrials.gov·otherRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Gait
Drug/Device/Intervention: Walking on an instrumented treadmill
Study type: Interventional
Intervention type: other

Sponsor & location

Primary sponsor: University Hospital, Ghent
Location: Ghent, Belgium

Timeline & enrollment

Phase: N/A
Start date: Jul 14, 2021
End date: Jan 01, 2023
Enrollment: 240 participants

Primary outcome

Kinematics,Kinetics,EMG,EMG synergies,Spatiotemporal parameters,Spatiotemporal parameters,Spatiotemporal parameters

Summary

The aim of this study is to collect a large set of norm/control data on an instrumented treadmill (the Gait Real-time Analysis Interactive Lab - GRAIL) at the university hospital of Ghent for the purpose of clinical studies as well as for clinical interpretation.  We hypothesize that this norm/control data will provide reference data of the normal gait patterns in the healthy population such that we can then use it to identify gait abnormalities in populations with pathology.  The following data will be collected on the GRAIL while subjects walk at different gait speeds: 3D kinematics, kinetics, and EMG.

ICD-10 classifications

Paralytic gaitAbnormalities of gait and mobilityOther and unspecified abnormalities of gait and mobilityAtaxic gaitFall on and from stairs and steps

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT04987346
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT04987346 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital, Ghent and is currently Recruiting. The study focuses on Gait. Target enrollment is 240 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.